Next 10 |
2024-05-20 10:58:01 ET Wall Street is feeling pretty good about AbbVie 's (NYSE: ABBV) performance in 2024 so far. Louise Chen from Cantor Fitzgerald recently initiated coverage on the stock with an overweight rating. Chen also slapped a $200 price target on the pharma stock, ...
2024-05-19 15:05:03 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Biopharma M&A surges year ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® PR Newswire - AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancin...
2024-05-15 17:50:05 ET AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call May 15, 2024, 13:40 ET Company Participants Robert Michael - CEO Roopal Thakkar - SVP, Chief Medical Officer, Global Therapeutics Jeffrey Stewart - COO Conference Call Pa...
2024-05-15 15:37:00 ET Summary The April/May 2024 edition of Fortune Magazine revealed its 100 Best Companies To Work For, or Besties. My latest Dogcatcher-quest to sniff-out the best dividend-buys found 56 dividend-paying Besties using YCharts 5/13/24 data. To be eligible for the...
2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...
2024-05-14 08:10:00 ET Summary Portfolio changes in April focus on BDCs, aiming to increase dividend income by at least $100 each month. Dividend income hit a new all-time record for April of $736, basically flat Y/Y and up 12% sequentially. Gifted Working Time 2024: Around 85...
2024-05-14 06:30:00 ET There are many dividend stocks on the market. Some will eventually cut or suspend their payouts due to company-specific, economic, or broader market issues. Those aren't the kind of dividend stocks that investors will want to own. Instead, income-seekers should try to...
2024-05-13 12:07:12 ET Summary First Trust Morningstar Dividend Leaders Index Fund ETF holds 90 stocks of companies with higher yields and 5-year dividend growth. The FDL ETF is well diversified across sectors, but quite concentrated in financials and its top holdings. FDL is ...
2024-05-13 11:49:48 ET More on AbbVie AbbVie: The Inevitable Is Happening Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade) AbbVie Inc. (ABBV) Q1 2024 Earnings Call Transcript BeiGene, AbbVie patent spat to get trial from USPTO...
News, Short Squeeze, Breakout and More Instantly...
2024-05-20 10:58:01 ET Wall Street is feeling pretty good about AbbVie 's (NYSE: ABBV) performance in 2024 so far. Louise Chen from Cantor Fitzgerald recently initiated coverage on the stock with an overweight rating. Chen also slapped a $200 price target on the pharma stock, ...
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...
Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company. The analyst notes that the company has ...